Gadoteridol

4 trials VVarious

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

2 Completed trials

3 Sponsors

8 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 1

Indications tested

Magnetic resonance imaging 2

Sponsors using this IMP

Bayer AG 2 Askbio Inc. 1 Iqvia Rds France 1

All trials

4 total

Long-term impact of GBCAs on motor and cognitive function following repeated Contrast-Enhanced MRI—ODYSSEY Pending

2024-515462-14-00 Phase IV 3 countries Iqvia Rds France
A study to improve the delivery of AB-1005 gene therapy into the brain Pending

2025-522441-21-00 Phase II 1 country Askbio Inc.
A study to compare how well gadoquatrane works and its safety with an already available contrast agent for MRI in people with known or suspe… Ended

2022-501884-41-00 Phase III 7 countries Bayer AG
A study to compare the effects and safety of gadoquatrane with an already used available contrast agent for MRI tests in people with any kno… Ended

2022-501885-24-00 Phase III 8 countries Bayer AG

Showing 1–4 of 4 trials

← All drugs A–Z